首页|First Affiliated Hospital of Harbin Medical University Reports Findings in Head and Neck Cancer (Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head-and-neck squamous cell carcinoma through machine learning)
First Affiliated Hospital of Harbin Medical University Reports Findings in Head and Neck Cancer (Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head-and-neck squamous cell carcinoma through machine learning)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Head and Neck Cancer is the subject of a report. Accordingto news reporting out of Harbin, People’s Republic of China, by NewsRx editors, research stated, “Headand-neck squamous cell carcinoma (HNSCC) patients often exhibit insensitivity to immunotherapy, leadingto treatment failure. Identifying potential biomarkers that can predict prognosis and improve the efficacyof treatment is crucial.”
HarbinPeople’s Republic of ChinaAsiaBiomarkersCancerCarcinomasCyborgsDiagnostics and ScreeningDrugs and TherapiesEmerging TechnologiesHead and Neck CancerHealth and MedicineImmunotherapyMachine LearningOncologyPrognostic Mark
NETL
NSTL
